Atlas Trials

Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

RecordFirmDate
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510)University of Washington2015-10-08
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer (NCT02388932)Case Comprehensive Cancer Center2015-03-03
Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT02196168)National Cancer Institute (NCI)2014-03-01
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617)National Cancer Institute (NCI)2011-02-10
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385)National Cancer Institute (NCI)2010-11-01
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer (NCT00458978)National Cancer Institute (NCI)2007-02-01

Track Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.